Metropolitan Life Insurance CO Singular Genomics Systems, Inc. Transaction History

Metropolitan Life Insurance CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jun 14, 2023	BUY	$1.82 - $2.71 $7,372 - $10,978	4,051 New	4,051 $8.14 Million
Q4 2022 Mar 30, 2023	BUY	$1.82 - $2.71 $6,384 - $9,506	3,508 Added 646.04%	4,051 $8,000
Q4 2022 Feb 15, 2023	BUY	$1.82 - $2.71 $7,372 - $10,978	4,051 New	4,051 $8,000
Q2 2022 Jun 20, 2023	BUY	$2.86 - $6.44 $1,552 - $3,496	543 New	543 $2,000
Q2 2022 Mar 30, 2023	SELL	$2.86 - $6.44 $8,705 - $19,603	-3,044 Reduced 84.86%	543 $2,000
Q2 2022 Aug 11, 2022	SELL	$2.86 - $6.44 $8,705 - $19,603	-3,044 Reduced 84.86%	543 $2,000
Q1 2022 Jun 20, 2023	BUY	$5.94 - $12.09 $21,306 - $43,366	3,587 New	3,587 $22,000
Q1 2022 Mar 30, 2023	SELL	$5.94 - $12.09 $2,756 - $5,609	-464 Reduced 11.45%	3,587 $22,000
Q1 2022 May 12, 2022	BUY	$5.94 - $12.09 $21,306 - $43,366	3,587 New	3,587 $23,000

1.43M

Ticker OMIC
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 71,193,296
Market Cap $1.52B
Description
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associat...

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

Stay updated on Metropolitan Life Insurance CO with notifications on news.